HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

idursulfase

for treating Hunter syndrome
Also Known As:
Elaprase
Networked: 90 relevant articles (17 outcomes, 25 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Muenzer, Joseph: 10 articles (01/2022 - 08/2006)
2. Giugliani, Roberto: 10 articles (10/2021 - 08/2006)
3. Beck, Michael: 7 articles (10/2017 - 08/2006)
4. Burton, Barbara K: 6 articles (10/2021 - 10/2010)
5. Harmatz, Paul: 6 articles (10/2021 - 08/2006)
6. Scarpa, Maurizio: 5 articles (10/2017 - 12/2010)
7. Whiteman, David A H: 5 articles (01/2017 - 02/2011)
8. Tylki-SzymaƄska, Anna: 4 articles (02/2022 - 01/2014)
9. Vijayaraghavan, Suresh: 4 articles (01/2022 - 08/2006)
10. Okuyama, Torayuki: 4 articles (06/2021 - 01/2010)

Related Diseases

1. Mucopolysaccharidosis II (Hunter Syndrome)
2. Inborn Genetic Diseases (Disease, Hereditary)
02/01/2008 - "The recent approval in the US, Europe, Canada and Japan of idursulfase for the treatment of Hunter syndrome introduces the first pharmacologic agent and indeed the first specific treatment directed towards this devastating genetic disease."
02/05/2016 - "To evaluate the effectiveness and safety of enzyme replacement therapy with idursulfase compared to other interventions, placebo or no intervention, for treating mucopolysaccharidosis type II. We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register (date of last search 23 November 2015).We also searched Embase, PubMed and the Literature Latino-Americana e do Caribe em Ciências da Saúde (LILACS) (date of last search 28 November 2015). "
01/08/2014 - "Enzyme replacement therapy with intravenous infusions of idursulfase has emerged as a new treatment for mucopolysaccharidosis type II. To evaluate the effectiveness and safety of enzyme replacement therapy with idursulfase compared to other interventions, placebo or no intervention, for treating mucopolysaccharidosis type II. We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register (date of last search 22 July 2013).We also searched EMBASE, PubMed and the Literature Latino-Americana e do Caribe em Ciências da Saúde (LILACS) (date of last search 09 July 2013). "
11/09/2011 - "Enzyme replacement therapy with intravenous infusions of idursulfase has emerged as a new treatment for mucopolysaccharidosis type II. To evaluate the effectiveness and safety of enzyme replacement therapy with idursulfase compared to other interventions, placebo or no intervention, for treating mucopolysaccharidosis type II. We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register (date of last search 01 September 2011).We also searched EMBASE, PubMed and the Literature Latino-Americana e do Caribe em Ciências da Saúde (LILACS) (date of last search October 2009). "
3. Cystic Fibrosis (Mucoviscidosis)
02/05/2016 - "To evaluate the effectiveness and safety of enzyme replacement therapy with idursulfase compared to other interventions, placebo or no intervention, for treating mucopolysaccharidosis type II. We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register (date of last search 23 November 2015).We also searched Embase, PubMed and the Literature Latino-Americana e do Caribe em Ciências da Saúde (LILACS) (date of last search 28 November 2015). "
01/08/2014 - "Enzyme replacement therapy with intravenous infusions of idursulfase has emerged as a new treatment for mucopolysaccharidosis type II. To evaluate the effectiveness and safety of enzyme replacement therapy with idursulfase compared to other interventions, placebo or no intervention, for treating mucopolysaccharidosis type II. We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register (date of last search 22 July 2013).We also searched EMBASE, PubMed and the Literature Latino-Americana e do Caribe em Ciências da Saúde (LILACS) (date of last search 09 July 2013). "
11/09/2011 - "Enzyme replacement therapy with intravenous infusions of idursulfase has emerged as a new treatment for mucopolysaccharidosis type II. To evaluate the effectiveness and safety of enzyme replacement therapy with idursulfase compared to other interventions, placebo or no intervention, for treating mucopolysaccharidosis type II. We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register (date of last search 01 September 2011).We also searched EMBASE, PubMed and the Literature Latino-Americana e do Caribe em Ciências da Saúde (LILACS) (date of last search October 2009). "
4. Disease Progression
5. Medically Unexplained Symptoms

Related Drugs and Biologics

1. Glycosaminoglycans
2. Enzymes
3. Biomarkers (Surrogate Marker)
4. Transferrin Receptors (Transferrin Receptor)
5. Heparitin Sulfate (Heparan Sulfate)
6. idursulfase
7. Antibodies
8. Lysergic Acid Diethylamide (LSD)
9. galsulfase
10. human GAA protein (Myozyme)

Related Therapies and Procedures

1. Enzyme Replacement Therapy
2. Intravenous Infusions
3. Therapeutics
4. Catheters
5. Enzyme Therapy